sedative hypnotics pharm Flashcards
benzodiazepines
alprazolam clonazepam diazepam midazolam triazolam
benzodiazepine antagonists
flumazenil
barbituates
phenobarbital
absorption of sedative-hypnotics
lipid solubility major determining factor for rate of CNS effects
all cross BBB, placenta, and breast milk
benzos meta
liver
cumulative toxicity (especially those w/long half lives)
if pt has hepatic insufficiency should use oxazempam or lorazepam
barbituates meta
hepatic
phenobarbital exception that 20-30% excreted unchanged (alkaline urine will increase excretion rate)
can have cumulative toxicity
benzo MOA
increase efficiency of GABA
DO NOT substitute for GABA itself, potentiates
increased frequency of ClCh opening
barbituates MOA
increase duration of GABA ClCh opening
at high concentations can open Chs w/o GABA
drugs which faciliate GABA actions
benzos
eszopiclone
zaleplon
zolpidem
GABA antagonists
flumazenil
inverse GABA agonists
beta-carbolines
produce anxiety and seizures
sedation
suppress CNS
reduce anxiety
benzos also exert dose-dependent anterograde amnesia
anticonvulsant efects
benzos and barbituates
zolpidem, zaleplon, and eszopiclone lack anticonvulsant activity
mm relaxation
benzos, carbamates
zolpidem, zaleplon, and eszopiclone do not cause mm relaxation
flumazenil MOA
binds benzo binding site of GABAR acting as competitive antagonists